Comparison of the therapeutic efficacy of oral doses of fluconazole and griseofulvin in a guinea pig model of dermatophytosis

Journal of Antibiotics

Volumn 53, Issue 2, 2000, Pages 207-210

  Nagino, Kenji ^a   Shimohira, Hiroshi ^a   Ogawa, Masatoshi ^a   Uchida, Katsuhisa ^b   Yamaguchi, Hideyo ^b  

^a PFIZER INC   (United States)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; GRISEOFULVIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DERMATOMYCOSIS; DRUG EFFICACY; EXPERIMENTAL INFECTION; FEMALE; GUINEA PIG; NONHUMAN; PRIORITY JOURNAL;

EID: 0034092784     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.53.207     Document Type: Article

References (25)

1. MILATOVIC, D. & A. VOSS: Efficacy of fluconazole in the treatment of systemic fungal infections. Eur. J. Clin. Microbiol. Infect. Dis. 11: 395-402, 1992
2. GRANT, S. M. & S. P. CLISSOLD: Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses. Drugs 39: 877-916, 1990
3. DE BERSAQUES, J.; J. R. BJERKE, S. BORELLI, A. C. BROWN, F. COTTENOT, F. DANIEL, B. DUPONT, F. GSCHNAIT, M. HEENEN, B. V. JEGASOTHY, M. KRAMER, C. LAPIERE, K. H. NELDER, E. A. OLSEN, L. C. PARISH, Y. PRIVAT, R. C. SAVIN, P. SCHNABEL, B. SHUBERT, S. E. STENVOLT, H. B. SVINDLAND, E. TSCHEN, C. F. H. VICKERS, A. G. WADE, D. WALLACH & N. ZAIAS: Comparison of oral fluconazole and topical clotrimazole in the treatment of fungal infections of the skin: European and American experience. Int. J. Dermatol. 31(Suppl. 2): 21-26, 1992
4. DE CUYPER, C.; J. DE BERSAQUES, J. DELESCLUSE, D. GRIGORIU, E. HANEKE, R. J. HAY, B. HENTZER, A. LUGER, H. E. MENKE & J. SONDERGAARD: Evaluation of four oral daily doses of fluconazole in the treatment of cutaneous mycoses. Int. J. Dermatol. 31 (Suppl.2): 8-11, 1992
5. DE CUYPER, C.; P. AMBLARD, J. AUSTAD, J. BAZEX, P. BOHMANN, J. DE BERSAQUES, J. B. GARREL, M. GJORUD, E. GROSSHANS, L. HANSSEN, N. HJORTH, H., HOLZMANN, G. JEANPIERRE, J. JOHNSEN, B. LANGELAND, J. LANGELAND, P. LAURET, R. M. MACKIE, K. MEINICHE, N. MORK, J. P. ORTONNE, A. A. RUISSANT, N. ROSMAN, J. SONDERGAARD, G. STUTTGEN, E. SVEJGAARD & J. THORVALDSEN: Noncomparative study of fluconazole in the treatment of patients with common fungal infections of the skin. Int. J. Dermatol. 31 (Suppl. 2): 17-20, 1992
6. FISCHBEIN, A.; E. HANEKE, K. LANCER, O. MALE, R. MOHN, H. MULLER, M. O'CONNOLY, H. TRONNIER & F. VOGEL: Comparative evaluation of oral fluconazole and oral ketoconazole in the treatment of fungal infections of the skin. Int. J. Dermatol. 31 (Suppl. 2): 12-16, 1992
7. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. Document M27-A. National Committee for Clinical Laboratory Standards, Villanova, Pa. 1997
8. ANAISSIE, E.; V. PAETZNICK & G. P. BODEY: Fluconazole susceptibility testing of Candida albicans: microtiter method that is independent of inoculum size, temperature, and time of reading. Antimicrob. Agents Chemother. 35: 1641-1646, 1991
9. RINALDI, M. G.: Laboratory evaluation of antifungal agents: a brief overview. Clin. Infect. Dis. 14 (Suppl. 1): S 130-133, 1992
10. MACKERROW, S. D.; J. M. MERRY & P. D. HOEPRICH: Effect of buffers on testing of Candida species susceptibility to flucytosine. J. Clin. Microbiol. 25: 885-888, 1987
11. DOERN, G. V.; T. A. TUBERT, K. CHAPIN & M. G. RINALDI: Effect of medium composition on results of macrobroth dilution antifungal susceptibility testing of yeasts. J. Clin. Microbiol. 24: 507-511, 1986
12. REX, J.; M. A. PFALLER, M. G. RINALDI, A. POLAK & J. H. GALGIANI: Antifungal susceptibility testing. Clin. Microbiol. Rev. 6: 367-381, 1993
13. UCHIDA, K.; H. YAMAGUCHI & K. SHIBUYA: The therapeutic effects of itraconazole, a new triazole antifungal agent, for experimental fungal infections. Jpn. J. Antibiotics 44: 588-599, 1991
14. UCHIDA, K. & H. YAMAGUCHI: Therapeutic efficacy of oral administration of terbinafine in guinea pig trichophytosis model. Jpn. J. Med. Mycol. 34: 485-491, 1993
15. OHMI, T.; S. KONAKA, M. UCHIDA & H. YAMAGUCHI: Antifungal activity of a new agent latoconazole in two tinea models. Arzneim.-Forsch./Drug Res. 41: 847-851, 1991
16. UCHIDA, K.; A. MATSUZAKA & H. YAMAGUCHI: Therapeutic effect of amorolfine on experimental dermatophytosis. Jpn. J. Antibiotics 44: 1020-1031, 1991
17. YOSHIDA, T.; K. UCHIDA & H. YAMAGUCHI: An ATP Bioluminescence assay applicable to rapid fluconazole susceptibility testing of dermatophytes. Microbiol. Immunol. 41: 377-396, 1997
18. Report of the Committee of Clinical Laboratory Standards-1994 Jpn. J. Med. Mycol. 36: 87-95, 1995
19. PIERARD, G. E.; J. E. ARRESE & C. PIERARD-FRANCHIMONT: Treatment and prophylaxis of tinea infections. Drugs 52: 209-224, 1996
20. DEGREEF, H. J. & P. R. DEDONCKER: Current therapy of dermatophytosis. J. Am. Acad. Dermatol. 31: S25-30, 1994
21. IWATA, K.; A. MATSUDA, Y. ISSHIKI & Y. YONEKURA: Fundamental studies on antifungal activity of griseofulvin on various pathogenic microorganisms, especially dermatophytes. J. Med. Mycol. 1: 264-273, 1960
22. RICHARDSON, K.; K. W. BRAMMER, M. S. MARRIOTT & P. F. TROKE: Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes. Antimicrob. Agents Chemother. 27: 832-835, 1985
23. FAERGEMANN, J. & H. LAUFEN: Levels of fluconazole in serum, stratum corneum, epidermis-dermis (without stratum corneum) and eccrine sweat. Clin. Exp. Dermatol. 18: 102-106, 1993
24. HAY, R. J.: Pharmacokinetic evaluation of fluconazole in skin and nails. Int. J. Dermatol. 31 (Suppl. 2): 6-7, 1992
25. WILDFEUER, A.; J. FAERGEMANN, H. LAUFEN, G. PFAFF, T. ZIMMERMANN, H. P. SEIDL & P. LACH: Bioavailability of fluconazole in the skin after oral medication. Mycoses. 37: 127-130, 1994